Cetera Investment Advisers
XBI icon

Cetera Investment Advisers’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Cetera Investment Advisers’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$221K Buy
+10,000
New +$1.25M ﹤0.01% 4222

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cetera Investment Advisers's XBI Position: Q1 2026 in Review

Cetera Investment Advisers reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.57% in Q1 2026, selling an estimated $116K and leaving 162,254 shares worth $20.7M. The position accounts for 0.02% of the portfolio, ranked #663.

Cetera Investment Advisers first reported a position in XBI in Q2 2019 and has held it in 28 quarters since. 815 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Cetera Investment Advisers held 162,254 shares of State Street SPDR S&P Biotech ETF worth $20.7M as of Q1 2026.
  • Cetera Investment Advisers sold 927 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $116K.
  • State Street SPDR S&P Biotech ETF made up 0.02% of Cetera Investment Advisers's portfolio in Q1 2026, its #663 holding.
  • Cetera Investment Advisers first reported a position in State Street SPDR S&P Biotech ETF in Q2 2019 and has held it in 28 quarters since.
  • 815 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.